Retour

Paramount Bed Holdings Co., Ltd.

Qualité des données : 100%

Survendu

PBHDF

OTC Healthcare Medical - Instruments & Supplies

19,74 €

0,00 € (0,00%)

Cap. Boursière : 1,15B

Fourchette du Jour

19,74 € 19,74 €

Fourchette 52 Semaines

—

Volume

900

Moyenne 50J / 200J

— / —

Clôture Précédente

19,74 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique	Action	Médiane du Secteur
P/E	0,1	0,4
P/B	0,0	2,9
ROE %	6,7	3,7
Net Margin %	8,4	3,9
Rev Growth 5Y %	5,6	10,0
D/E	0,1	0,2

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période	BPA Est.	CA Est.	Analystes
FY2028	203,99 € 203,99 € – 203,99 €	130 B	1
FY2027	191,54 € 191,54 € – 191,54 €	120 B	1
FY2026	180,80 € 180,80 € – 180,80 €	110 B	1

Points Clés

Revenue grew 5,64% annually over 5 years — modest growth

Earnings declined -14,49% over the past year

Debt/Equity of 0,05 — conservative balance sheet

Generating 5,99B in free cash flow

P/E of 0,13 — trading at a low valuation

Revenue growth is decelerating — 1Y growth trails 5Y average by 3,22%

Croissance

Revenue Growth (5Y)

5,64%

Revenue (1Y)2,42%

Earnings (1Y)-14,49%

FCF Growth (3Y)1099,64%

Qualité

Return on Equity

6,65%

ROIC6,75%

Net Margin8,37%

Op. Margin11,95%

Sécurité

Debt / Equity

0,05

Current Ratio3,67

Interest Coverage78,65

Valorisation

P/E Ratio

0,13

P/B Ratio0,01

EV/EBITDA-2,08

Dividend Yield0,03%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	2,42%	Revenue Growth (3Y)	4,72%
Earnings Growth (1Y)	-14,49%	Earnings Growth (3Y)	-0,72%
Revenue Growth (5Y)	5,64%	Earnings Growth (5Y)	1,34%
Profitability
Revenue (TTM)	108,58B	Net Income (TTM)	9,08B
ROE	6,65%	ROA	4,96%
Gross Margin	48,40%	Operating Margin	11,95%
Net Margin	8,37%	Free Cash Flow (TTM)	5,99B
ROIC	6,75%	FCF Growth (3Y)	1099,64%
Safety
Debt / Equity	0,05	Current Ratio	3,67
Interest Coverage	78,65	Dividend Yield	0,03%
Valuation
P/E Ratio	0,13	P/B Ratio	0,01
P/S Ratio	0,01	PEG Ratio	-1,45
EV/EBITDA	-2,08	Dividend Yield	0,03%
Market Cap	1,15B	Enterprise Value	-26,99B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	108,58B	106,02B	99,01B	90,35B	87,17B
Net Income	9,08B	10,62B	9,22B	9,09B	8,61B
EPS (Diluted)	159,24	182,61	158,37	156,39	148,15
Gross Profit	52,56B	50,63B	355,30M	353,51M	365,95M
Operating Income	12,98B	13,82B	13,45B	12,34B	11,58B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	183,03B	180,02B	1,30B	1,35B	1,40B
Total Liabilities	45,74B	44,01B	328,13M	349,99M	366,81M
Shareholders' Equity	137,28B	136,01B	128,70B	121,67B	113,82B
Total Debt	6,81B	5,96B	5,51B	6,14B	7,13B
Cash & Equivalents	34,94B	33,83B	343,71M	373,47M	368,82M
Current Assets	94,53B	95,50B	97,14B	94,04B	86,14B
Current Liabilities	25,76B	24,90B	26,30B	25,39B	23,72B

Scores de Stratégies

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)

Rank = position among all matches

Custom Deep Value Investing (Seth Klarman)

#428 of 820

Value Defensive Investing (Benjamin Graham)

#590 of 708

Activité Récente

Entré Deep Value Investing (Seth Klarman)

Mar 24, 2026

Entré Defensive Investing (Benjamin Graham)

Mar 24, 2026